4:43 PM
 | 
Jan 29, 2019
 |  BC Extra  |  Company News

Allergan sheds $4.5B in market cap on 4Q18 earnings

Allergan plc (NYSE:AGN) lost $13.57 to $145.12 on Tuesday after it reported a $4.3 billion net loss in 4Q18 and presented 1Q19 guidance well below the Street’s consensus. The stock move translates to a loss in market cap over $4.5 billion.

Allergan’s 4Q18 GAAP loss per share of $12.83 is a stark reversal to the $9.97 GAAP EPS and $3.1 billion income gain it recorded...

Read the full 301 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >